Olivia Putri Chairunnisa, et al. , translators. “Which Anti-VEGF Therapy (Ranibizumab, Bevacizumab, or Aflibercept) Demonstrates The Most Cost-Effective Outcomes For Treating Age-Related Macular Degeneration ? : A Systematic Review”. The Indonesian Journal of General Medicine, vol. 12, no. 3, May 2025, pp. 1-48, https://doi.org/10.70070/vbsedq58.